Dis-Chem's Founding Family Sells Over R1.5 Billion in Shares to Coronation Asset Management

In what can be described as a significant realignment of ownership, Dis-Chem Pharmacies has announced the sale of a substantial portion of the founding family's shares in the company. Ivan Saltzman, who founded the company with his wife Lynette in 1978, sold R1.43 billion worth of shares to Coronation Asset Management through Ivlyn Local Investment Holdings, an entity associated with the Saltzman family. Additionally, their son, Saul Saltzman, parted with 3 million shares for R87.9 million, totaling the family's divestment to over R1.5 billion.

This transaction has reduced Ivlyn's stake in Dis-Chem from 35.12% to 29.31%. Coronation, through this acquisition, has seen its beneficial interest in the pharmaceutical retail giant grow to an impressive 29.83%. This purchase by Coronation underscores confidence in Dis-Chem’s business model and its retail footprint which spans 250 stores across South Africa. The company's robust growth trajectory is indicated by its reported revenue of R32 billion in its latest financial results.

The sale forms part of a broader corporate succession and realignment, coinciding with Ivan Saltzman’s recent step down as CEO in June 2023, after 45 years at the helm. His successor, Rui Manuel Morais, who was Dis-Chem's former CFO, and other senior executives are set to acquire around R750 million worth of shares from the Saltzman family. This move aims to ensure the new leadership's vested interest in the continued success of the company as they take on their new roles.

Ivan Saltzman's decision to sell comes as part of a strategic plan laid out for a smooth leadership transition. The plans include the divestment of 32.25 million ordinary shares – 3.75% of the issued share capital – to Morais amongst other key senior executives. Such a decision speaks to a strategic business move aimed at instilling a deeper sense of commitment within the company's management while also potentially broadening the shareholder base.

In tandem with these share sales, Dis-Chem took a significant step towards consolidating its assets by purchasing its head office and Midrand distribution center from the Saltzmans and other directors for about R500 million. This move aims at ensuring that Dis-Chem owns all its core distribution centers and is in line with its long-term strategic objective to have a positive impact on the income statement with minimal balance sheet effects.

The sale of these shares by the Saltzmans and their reshuffling of assets seems aligned with the company’s long-term strategic goals and sustainability. Moreover, the introduction of new owners like Coronation provides a diversification that could bode well for corporate governance and growth perspectives while keeping a keen eye on profitability and market expansion.

The implications of this large-scale divestiture of shares, the related property transaction, and the broader leadership transition are yet to fully manifest. However, these are clear indicators of Dis-Chem's intent to streamline its business operations and management, paving the way for a new growth journey post-Ivan Saltzman’s remarkable 45-year tenure.